Ballentine Partners’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
TE
MFG
BCG
FFA
GI
BHWM
VCM
CA
APW
Ballentine Partners's REPL Position: Q2 2026 in Review
Ballentine Partners increased its Replimune Group (REPL) stake by 1.8% in Q2 2026, buying an estimated $2.45K and bringing the position to 22,046 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #912.
Ballentine Partners first reported a position in REPL in Q3 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold REPL as of Q2 2026.
- Ballentine Partners held 22,046 shares of Replimune Group worth $244K as of Q2 2026.
- Ballentine Partners bought 400 Replimune Group shares in Q2 2026, an estimated $2.45K.
- Replimune Group made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #912 holding.
- Ballentine Partners first reported a position in Replimune Group in Q3 2025 and has held it in 4 quarters since.
- 12 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.